HealthEquity, Inc. (NASDAQ:HQY) Position Raised by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC raised its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 35.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 772,781 shares of the company's stock after purchasing an additional 203,617 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 0.89% of HealthEquity worth $74,148,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Barclays PLC grew its holdings in shares of HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after buying an additional 112,667 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in HealthEquity in the 3rd quarter worth approximately $260,000. Wilmington Savings Fund Society FSB acquired a new position in HealthEquity in the 3rd quarter valued at $150,000. Franklin Resources Inc. lifted its stake in shares of HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after purchasing an additional 11,659 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock worth $120,000 after purchasing an additional 309 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently weighed in on HQY shares. KeyCorp cut their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Barrington Research reiterated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Wells Fargo & Company raised their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $111.75.

HealthEquity Stock Performance

Shares of HealthEquity stock traded up $0.04 during trading on Friday, hitting $85.87. 559,483 shares of the stock were exchanged, compared to its average volume of 771,464. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The stock's fifty day moving average is $91.87 and its 200 day moving average is $96.42. The stock has a market cap of $7.43 billion, a PE ratio of 78.78, a P/E/G ratio of 1.60 and a beta of 0.49.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 20,381 shares of company stock worth $1,781,432. Insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.